1. Home
  2. PFAI vs GDTC Comparison

PFAI vs GDTC Comparison

Compare PFAI & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PFAI
  • GDTC
  • Stock Information
  • Founded
  • PFAI 2015
  • GDTC 2018
  • Country
  • PFAI Canada
  • GDTC Singapore
  • Employees
  • PFAI N/A
  • GDTC N/A
  • Industry
  • PFAI Farming/Seeds/Milling
  • GDTC Biotechnology: Pharmaceutical Preparations
  • Sector
  • PFAI Consumer Staples
  • GDTC Health Care
  • Exchange
  • PFAI Nasdaq
  • GDTC Nasdaq
  • Market Cap
  • PFAI 21.1M
  • GDTC 21.5M
  • IPO Year
  • PFAI 2025
  • GDTC 2023
  • Fundamental
  • Price
  • PFAI $1.95
  • GDTC $1.91
  • Analyst Decision
  • PFAI
  • GDTC Buy
  • Analyst Count
  • PFAI 0
  • GDTC 1
  • Target Price
  • PFAI N/A
  • GDTC $5.00
  • AVG Volume (30 Days)
  • PFAI 239.8K
  • GDTC 18.1K
  • Earning Date
  • PFAI 01-01-0001
  • GDTC 01-01-0001
  • Dividend Yield
  • PFAI N/A
  • GDTC N/A
  • EPS Growth
  • PFAI N/A
  • GDTC N/A
  • EPS
  • PFAI 0.03
  • GDTC N/A
  • Revenue
  • PFAI $3,289,862.00
  • GDTC $368,838.00
  • Revenue This Year
  • PFAI N/A
  • GDTC $5.37
  • Revenue Next Year
  • PFAI N/A
  • GDTC N/A
  • P/E Ratio
  • PFAI $62.00
  • GDTC N/A
  • Revenue Growth
  • PFAI 56.60
  • GDTC N/A
  • 52 Week Low
  • PFAI $1.55
  • GDTC $1.20
  • 52 Week High
  • PFAI $4.40
  • GDTC $4.05
  • Technical
  • Relative Strength Index (RSI)
  • PFAI N/A
  • GDTC 35.89
  • Support Level
  • PFAI N/A
  • GDTC $1.85
  • Resistance Level
  • PFAI N/A
  • GDTC $1.95
  • Average True Range (ATR)
  • PFAI 0.00
  • GDTC 0.10
  • MACD
  • PFAI 0.00
  • GDTC -0.02
  • Stochastic Oscillator
  • PFAI 0.00
  • GDTC 23.53

About PFAI Pinnacle Food Group Limited Class A Common Shares

Pinnacle Food Group Ltd is a provider of smart farming solutions focused on vertical and hydroponic farming. The company focuses on promoting sustainable food security by developing and building customized smart farming systems for customers based on the systematic integration of technology, hardware, and software, coupled with a full range of integrated supply and technical services. It sells hydroponic growing systems and technical support services to individual households and community groups, and is developing a hydroponic growing system for urban farms. Geographically, the company generates the majority revenue from Canada, followed by New Zealand.

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

Share on Social Networks: